# EMRELIS
> **BLA761384** · Biologics License Application · Sponsor: ABBVIE INC · Approved 2025-05-14
## Drug
- **FDA Application Number:** BLA761384
- **Application type:** Biologics License Application
- **Brand name:** EMRELIS
- **Generic name:** TELISOTUZUMAB VEDOTIN
- **Active ingredients:** TELISOTUZUMAB VEDOTIN-TLLV
- **Dosage form:** VIAL
- **Route:** SINGLE-DOSE
- **Marketing status:** Prescription
- **Sponsor:** ABBVIE INC
- **Manufacturer:** AbbVie Inc.
- **First approval:** 2025-05-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761384)
---
*AI Analytics · CC0 1.0*